Total voting rights

1 May 2024

PayPoint Plc (the "Company") - Total Voting Rights and Capital

In conformity with DTR 5.6.1 the Company hereby notifies the market of the following:

As of 30 April 2024, the Company's share capital consisted of 72,696,192 ordinary shares of 1/3 pence each. Each ordinary share carries the right to one vote in relation to all circumstances at general meetings of the Company. The Company does not hold any shares in Treasury.

The above figure of 72,696,192 may be used by shareholders and others with notification obligations as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

PayPoint Plc

Julia Herd, on behalf of Indigo Corporate Secretary Limited, Company Secretary

+44 (0)7542031173

Steve O’Neill, Corporate Affairs and Marketing Director, +44 (0)7919 488066

LEI Number: 5493004YKWI8U0GDD138

You May Also Be Interested In

• Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
• Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
• Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented at the ESMO 202